Patent intelligence · US
US 6149891
X-ray contrast medium and method for protecting against harmful effects thereof
X-ray contrast medium and method for protecting against harmful effects thereof
Patent details — US 6149891
- Jurisdiction
- US
- Status
- expired
- Grant date
- Nov 21, 2000
- Expiration
- Nov 16, 2020
- Applicant
- Jade Holding Inc. B.V.I
- Claims
- 3
- CPC classes
- A61K, A61K45/06, A61K49/0002, A61K49/0452
Quick answer
US 6149891 (X-ray contrast medium and method for protecting against harmful effects thereof) is held by Jade Holding Inc. B.V.I. Status: expired. Granted Nov 21, 2000. Expires Nov 16, 2020 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Jade Holding Inc. B.V.I
- Grant date
- Expiration
- Claims
- 3
- CPC classes
- A61K, A61K45/06, A61K49/0002, A61K49/0452
More from Jade Holding Inc. B.V.I
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 6149891?
US 6149891 (X-ray contrast medium and method for protecting against harmful effects thereof) is held by Jade Holding Inc. B.V.I. Status: expired. Granted Nov 21, 2000. Expires Nov 16, 2020 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 6149891?
Jade Holding Inc. B.V.I is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 2 pharmaceutical patents for this assignee.
When does US 6149891 expire?
Our index shows an expiration date of Nov 16, 2020 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.